Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2015-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Adductor Canal Blockade in Anterior Cruciate Ligament Surgery
NCT02419261
Continuous Adductor Canal Block for Total Knee Arthroplasty Analgesia
NCT02387021
The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty.
NCT02374008
Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery
NCT03698006
Comparison of Regional Anesthesia Techniques After Total Knee Arthroplasty
NCT03143738
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators want to compare the efficacy and safety of this block compared to the femoral and sciatic block.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Femoral nerve blockade
In this group, patient will benefit of an ultrasound guided femoral nerve blockade with continuous catheter infusion as (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.
Analgesic nerve blockade (Ropivacaine)
Analgesic nerve blockade (Ropivacaine) for total knee replacement surgery.
Total knee replacement surgery.
Total knee replacement surgery.
Adductor canal blockade
In this group, patient will benefit of an ultrasound guided adductor canal blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for for total knee replacement surgery.
Analgesic nerve blockade (Ropivacaine)
Analgesic nerve blockade (Ropivacaine) for total knee replacement surgery.
Total knee replacement surgery.
Total knee replacement surgery.
Subgluteal sciatic nerve blockade
In this group, patient will benefit of an ultrasound guided subgluteal sciatic nerve blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.
Analgesic nerve blockade (Ropivacaine)
Analgesic nerve blockade (Ropivacaine) for total knee replacement surgery.
Total knee replacement surgery.
Total knee replacement surgery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analgesic nerve blockade (Ropivacaine)
Analgesic nerve blockade (Ropivacaine) for total knee replacement surgery.
Total knee replacement surgery.
Total knee replacement surgery.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* coagulation disorder,
* infection at the puncture site,
* preexisting neuropathy,
* allergy to local anesthetics,
* renal or hepatocellular insufficiency,
* context of chronic pain,
* drugs abuse,
* pregnant patient.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pierre Goffin
Clinical assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Francois Brichant
Role: STUDY_CHAIR
University of Liege
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University og Liege, University Hospital
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-000677-39
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.